CliffBio
small molecule

SENSIPAR

CINACALCET HYDROCHLORIDE

Loss of exclusivitySeptember 2026latest FDA-listed patent expiry
CompanyAmgen →View the full company profile on CliffBio

Drug detail

Brand nameSENSIPAR
Active ingredientCINACALCET HYDROCHLORIDE
StrengthEQ 30MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2004
Marketing statusDISCN

Listed patents

PatentExpiresType
7829595September 2026product
9375405September 2026product

More from Amgen

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

SENSIPAR patent cliff — loss of exclusivity September 2026 | CliffBio